Home
Scholarly Works
A phase II study of UCN-01 in combination with...
Journal article

A phase II study of UCN-01 in combination with topotecan in patients with advanced recurrent ovarian cancer: A Princess Margaret Phase II Consortium Trial

Authors

Hirte HW

Journal

Journal of Clinical Oncology, Vol. 23, No. 16_suppl, pp. 3127–3127

Publisher

American Society of Clinical Oncology (ASCO)

Publication Date

June 1, 2005

DOI

10.1200/jco.2005.23.16_suppl.3127

ISSN

0732-183X
View published work (Non-McMaster Users)

Contact the Experts team